Select Equities
Healthcare & Wellbeing Investor Conference
Clover Corporation Presentation
Peter Davey - Managing Director & CEO 2 May 2016
Vision and Mission Statement
Vision: To optimise the health and development of adults, infants and children.
Mission: To deliver science based bioactives which provide health benefits to adults, infants, children and to the medical food markets.
2016 Half Year Performance Highlights
Total Revenue up 23.9% driven by improved demand
Net Profit $801K up 12.6% on half year 2015
Operating expenses down 2.5% as a % of revenue on previous year
Revenue from new customers is 16% continues positive trend
Inventory managed at
$13m in line with revenue growth
Balance sheet remains strong with no debt and cash of $7m
Clover's Value Chain
Product source
Fish
Omega 3 - EPA / DHA Omega 6 - ARA
Single Cell
Other Marine
Crude processors
Market Participants
Refiners
Encapsulation
Clover primarily operates in this sector of the supply chain
Sales and distribution
Applications / Markets
Pharmaceutical DietarySupplements
Food and Beverage
Animal food Infant nutrition Clinical
nutrition
Final Consumers
Clover Corporation Limited issued this content on 02 May 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 02 May 2016 00:53:05 UTC. Original document available at http://clients.weblink.com.au/clients/clover/article.asp?asx=CLV&view=2920238 |